🇺🇸 FDA
Patent

US 10420758

Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof

granted A61KA61K31/454A61K45/06

Quick answer

US patent 10420758 (Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/454, A61K45/06